Low-dose etoposide: a potential therapy for myelodysplastic syndromes

This publication has 11 references indexed in Scilit:

• Topoisomerase Inhibitors Have Potent Differentiation‐inducing Activity for Human and Mouse Myeloid Leukemia Cells
  Japanese Journal of Cancer Research, 1991
• Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia
  New England Journal of Medicine, 1990
• Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia
  Cancer, 1990
• TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKAEMIA WITH LOW DOSE ETOPOSIDE
  British Journal of Haematology, 1989
• Durable response to etoposide‐loaded platelets in refractory immune thrombocytopenic purpura: A case report
  American Journal of Hematology, 1988
• The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide
  British Journal of Cancer, 1985
• Acute myelogenous leukemia: Successful treatment of relapse with cytosine arabinoside, VP 16ndash;213, vincristine and vinblastine (A-triple-V)
  European Journal of Cancer and Clinical Oncology, 1982
• Proposals for the classification of the myelodysplastic syndromes
  British Journal of Haematology, 1982
• Pharmacokinetics of VP16-213 given by different administration methods
  Cancer Chemotherapy and Pharmacology, 1982
• Reporting results of cancer treatment
  Cancer, 1981